Literature DB >> 31236729

Changes in acute blood purification therapy in critical care: republication of the article published in the Japanese Journal of Artificial Organs.

Taka-Aki Nakada1, Shigeto Oda2, Ryuzo Abe2, Noriyuki Hattori2.   

Abstract

Acute blood purification therapy is an essential artificial organ in critical care. In the review article, looking back on the history, we describe our present knowledge and techniques of acute blood purification therapy in critical care. The topics include continuous hemodiafiltration (CHDF), online HDF as an artificial liver support, blood purification therapy aiming to remove pathogenic substances of sepsis, a procedure for connecting a CRRT device into an extra-corporeal membrane oxygenation circuit, and replacement fluid for CHDF. We also raise remaining issues and clarify the future direction of acute blood purification therapy in critical care. This review was created based on a translation of the Japanese review written in the Japanese Journal of Artificial Organs in 2017 (Vol. 46, No. 1, pp. 67-70), with adding some references.

Entities:  

Keywords:  Acute kidney injury; Artificial liver support; Continuous hemodiafiltration; Cytokine; Extra-corporeal membrane oxygenation; Sepsis; Septic shock

Mesh:

Year:  2019        PMID: 31236729     DOI: 10.1007/s10047-019-01113-7

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  23 in total

1.  Continuous hemofiltration/hemodiafiltration in critical care.

Authors:  Shigeto Oda; Hiroyuki Hirasawa; Hidetoshi Shiga; Kazuya Nakanishi; Ken-ichi Matsuda; Masataka Nakamura
Journal:  Ther Apher       Date:  2002-06

2.  Efficacy of high-flow dialysate continuous hemodiafiltration in the treatment of fulminant hepatic failure.

Authors:  Takehito Yokoi; Shigeto Oda; Hidetoshi Shiga; Ken-Ichi Matsuda; Tomohito Sadahiro; Masataka Nakamura; Hiroyuki Hirasawa
Journal:  Transfus Apher Sci       Date:  2008-12-30       Impact factor: 1.764

3.  A safe procedure for connecting a continuous renal replacement therapy device into an extracorporeal membrane oxygenation circuit.

Authors:  Natsumi Suga; Yosuke Matsumura; Ryuzo Abe; Noriyuki Hattori; Taka-Aki Nakada; Shigeto Oda
Journal:  J Artif Organs       Date:  2017-03-24       Impact factor: 1.731

4.  Proteome analysis of hemofilter adsorbates to identify novel substances of sepsis: a pilot study.

Authors:  Tomoaki Hashida; Taka-Aki Nakada; Mamoru Satoh; Keisuke Tomita; Rui Kawaguchi; Fumio Nomura; Shigeto Oda
Journal:  J Artif Organs       Date:  2016-11-17       Impact factor: 1.731

5.  The Japanese Clinical Practice Guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  J Intensive Care       Date:  2018-08-13

6.  High recovery rate of consciousness by high-volume filtrate hemodiafiltration for fulminant hepatitis.

Authors:  Keiichi Fujiwara; Ryuzo Abe; Shin Yasui; Osamu Yokosuka; Naoya Kato; Shigeto Oda
Journal:  Hepatol Res       Date:  2018-11-09       Impact factor: 4.288

7.  Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial.

Authors:  Alexander Zarbock; John A Kellum; Christoph Schmidt; Hugo Van Aken; Carola Wempe; Hermann Pavenstädt; Andreea Boanta; Joachim Gerß; Melanie Meersch
Journal:  JAMA       Date:  2016 May 24-31       Impact factor: 56.272

8.  The change in renal replacement therapy on acute renal failure in a general intensive care unit in a university hospital and its clinical efficacy: a Japanese experience.

Authors:  Yoh Hirayama; Hiroyuki Hirasawa; Shigeto Oda; Hidetoshi Shiga; Kazuya Nakanishi; Kenichi Matsuda; Masataka Nakamura; Takeshi Hirano; Takeshi Moriguchi; Eizo Watanabe; Masakazu Nitta; Ryuzo Abe; Takaaki Nakada
Journal:  Ther Apher Dial       Date:  2003-10       Impact factor: 1.762

9.  Continuous hemodiafiltration with PMMA Hemofilter in the treatment of patients with septic shock.

Authors:  Taka-Aki Nakada; Shigeto Oda; Ken-Ichi Matsuda; Tomohito Sadahiro; Masataka Nakamura; Ryuzo Abe; Hiroyuki Hirasawa
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

10.  Phoxilium(®) reduces hypophosphataemia and magnesium supplementation during continuous renal replacement therapy.

Authors:  Gabriela Godaly; Ola Carlsson; Marcus Broman
Journal:  Clin Kidney J       Date:  2015-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.